Sorry, you need to enable JavaScript to visit this website.

Understanding Clinical trials > I am a clinical trial participant 

I am a Clinical Trial participant

The following section was created using several sources of information considered as reliable and transferable for CDG. The goal is to help you understand clinical trials from a participant’s side of view. 

 

 

 

What to expect once you’ve joined a Clinical Trial?

Once you’ve joined a clinical trial, it’s crucial that you adhere to the protocol, pay attention to your symptoms and potential side effects, attend study visits, and share your feedback. At this point, it's essential that you are aware of terms like Principal investigators (PIs) and co-principal investigators (co-PIs), Clinical research assistants (CRAs), Clinical research coordinators (CRCs), etc. 

 

 

 

What happens during a clinical trial?

As well as carrying out tests to find out how well a treatment is working, researchers will also look out for any side effects and you may be asked questions about any new symptoms you have. Researchers will also look at the wider effects of treatment on your life as a whole, not just its effects on symptoms. There are also detailed tests and questionnaires that are used to measure people’s quality of life. Some clinical trials will also look at the cost-effectiveness of treatments and their effects on other aspects of care, so you may also be asked about how the treatment affects other areas of your life such as: whether you are able to work during the treatment, the number of times you visit your doctor and nurse, travel, etc. Read more here

 

 

 

What happens at the end of a Clinical Trial?

After a clinical trial is completed, the researchers carefully examine information collected during the study before making decisions about the meaning of the findings and about further testing. After a phase I or II trial, the researchers decide whether to move on to the next phase or to stop testing the investigational drug or device because it was unsafe or ineffective. When a phase III trial is completed, the researchers examine the data and decide whether the results have medical importance.
Results from clinical trials are often published in peer-reviewed scientific journals. Peer review is a process by which experts review the report before it is published to ensure that the analysis and conclusions are sound. If the results are particularly important, they may be featured in news media and discussed at scientific meetings and by patient advocacy groups before they are published. Once a new approach has been proven safe and effective in a clinical trial, it may become the standard of medical practice. Continue reading here. 
Additional resources for information related to understanding clinical trials for patients and their families can be found at:

 

Didn't find what you are looking for?

Your question may help others


 

 

Author

Joana Grilo Sci and Volunteer Program Nova School of Science and Technology 2021. 

Disclaimer

The Site cannot and does not contain medical or health advice. The information is provided for general informational and educational purposes only and is not a substitute for professional advice.
Accordingly, before taking any actions based upon such information, we encourage you to consult with the appropriate professionals. We do not provide any kind of medical or health advice. The use or reliance of any information contained on this site is solely at your own risk.
 

Follow Us

Like the World CDG Organization Facebook Page. Share the page on your own timeline, and tell your friends to share it.
Follow us on Twitter and LinkedIn.
Subscribe to our Youtube channel and invite your friends to subscribe too.


Page modified at Wednesday, April 28, 2021 - 13:31